Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 30 Aug 2024

A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for denosumab

in Drugs Outcomes Research and Policies

Yue He
Rong Zhang
Huarui Shen
Yingqi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1339721

2,212 views
2 citations

Original Research

Published on 29 Aug 2024

Medication-related burden and its association with medication adherence among elderly tuberculosis patients in Guizhou, China: a cross-sectional study

in Drugs Outcomes Research and Policies

Yun Wang
Sisi Jian
Zhongfeng Huang
Huijuan Chen
Yuanxia Hu
Shilin Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1416005

1,422 views
1 citation

Original Research

Published on 29 Aug 2024

Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipients

in Drugs Outcomes Research and Policies

Huiying Zong
Yundi Zhang
Fengxi Liu
Xiaoming Zhang
Yilei Yang
Xiaohong Cao
Yue Li
Anan Li
Penglin Zhou
Rui Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1458838

1,759 views
3 citations

Specialty Grand Challenge

Published on 26 Aug 2024

Drug outcomes research and policies – trends and challenges

in Drugs Outcomes Research and Policies

Bernd Rosenkranz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476849

1,916 views
3 citations

Original Research

Published on 23 Aug 2024

Dexmedetomidine: a real-world safety analysis based on FDA adverse event reporting system database

in Drugs Outcomes Research and Policies

Yichun Shuai
Zhe Chen
Qiaoqian Wan
Jinzheng Wu
Xin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419196

2,338 views
1 citation

Original Research

Published on 21 Aug 2024

Initial dosage optimization of olanzapine in patients with bipolar disorder based on model-informed precision dosing: a study from the real world

in Drugs Outcomes Research and Policies

Xiao Chen
Ke Hu
Hao-Zhe Shi
Liang Chen
Yi-Jia Zhang
Su-Mei He
Cun Zhang
Dong-Dong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444169

1,648 views
1 citation

Original Research

Published on 20 Aug 2024

Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China

in Drugs Outcomes Research and Policies

Jingying Gao
Chaojie Liu
Yinming Li
Xizhuo Chen
Tianqin Xue
Yuqing Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362374

1,120 views

Review

Published on 19 Aug 2024

The burden of systemic therapy administration route in treating HER2-positive breast cancer (for patients, healthcare professionals, and healthcare system): a systematic literature review

in Drugs Outcomes Research and Policies

Luciana Castro Garcia Landeiro
Tamie de Camargo Martins
Ruth Bartelli Grigolon
Isabel Monteiro
Joana Bisol Balardin
Eduardo Padilha
Gilberto Amorim
Stephen Stefani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1338546

2,021 views

Original Research

Published on 16 Aug 2024

Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitus

in Drugs Outcomes Research and Policies

Anneleen Robberechts
Kaat Stas
Margot Puttemans
Laura Poppe
Stephane Steurbaut
Guido R. Y. De Meyer
Hans De Loof

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1359568

1,476 views
1 citation

Original Research

Published on 15 Aug 2024

Potentially inappropriate prescribing among older adults with hypertension in China: prevalence and related comorbidities across different outpatient settings

in Drugs Outcomes Research and Policies

Jiaqi Chen
Shuang Wang
Lvliang Lu
Yujie Yang
Kai Wang
Jing Zheng
Zhijiang Zhou
Pi Guo
Yunpeng Cai
Qingying Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439230

1,577 views

Original Research

Published on 14 Aug 2024

Cost-effectiveness of pembrolizumab plus chemotherapy vs. chemotherapy as first-line treatment for advanced biliary tract cancer in China and the US

in Drugs Outcomes Research and Policies

Xianmei Luo
Tingting Cai
Jinyan Wu
Xingyu Li
Xiaofan Wang
Haiying Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393559

1,973 views

Original Research

Published on 13 Aug 2024

Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data

in Drugs Outcomes Research and Policies

Kaidi Zhao
Yang Zhao
Shengxiang Xiao
Chen Tu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1458438

4,253 views
6 citations

Original Research

Published on 13 Aug 2024

Self-medication of adults and children in Poland - results from outpatient health care physicians online questionnaire

in Drugs Outcomes Research and Policies

Karolina Kłoda
Mateusz Babicki
Aleksander Biesiada
Małgorzata Gałązka-Sobotka
Iwona Kowalska-Bobko
Agnieszka Mastalerz-Migas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413811

2,363 views
2 citations

Original Research

Published on 12 Aug 2024

A disproportionality analysis of low molecular weight heparin in the overall population and in pregnancy women using the FDA adverse event reporting system (FAERS) database

in Drugs Outcomes Research and Policies

Huanying Xu
Ningning Xu
Yingju Wang
Haoxi Zou
Suzhen Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1442002

3,516 views

Original Research

Published on 09 Aug 2024

Adverse event reporting of the IGF-1R monoclonal antibody teprotumumab: a real-world study based on the US food and drug administration adverse event reporting system

in Drugs Outcomes Research and Policies

Jiawei Zhao
Yong Tao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393940

2,916 views
4 citations

Original Research

Published on 09 Aug 2024

Impact of changes in antihypertensive medication on treatment intensity at hospital discharge and 30 days afterwards

in Drugs Outcomes Research and Policies

Nuša Japelj
Mojca Kerec Kos
Maja Jošt
Lea Knez

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376002

890 views